Moderna, South Korea Explore Collaboration On MRNA Vaccines
Moderna Inc. (MRNA) and South Korea will explore potential areas of collaboration for research and development of mRNA vaccines and local manufacturing opportunities in South Korea, the company said in a statement.
Moderna and Samsung Biologics have reached a Manufacturing Services and Supply Agreement in which Samsung Biologics in South Korea will provide large scale, commercial fill-finish manufacturing for COVID-19 Vaccine Moderna intended for the supply of markets outside of the U.S. starting in the third quarter of 2021…READ ON
Collaboration Between Organizations Is the Key to Getting Ahead of the COVID-19 Pandemic
The COVID-19 pandemic has been raging for well over a year now. In January 2020, the novel coronavirus genome was mapped out, giving researchers the ability to track not only its spread but its lineages over time and across locations. Now, after a year of lockdowns, there’s reason for hope: vaccines are starting to take effect, with early evidence of their value visible in falling case numbers in some populations after rollout…READ ON